BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 38473786)

  • 1. Characterization of MYBL1 Gene in Triple-Negative Breast Cancers and the Genes' Relationship to Alterations Identified at the Chromosome 8q Loci.
    Player A; Cunningham S; Philio D; Roy R; Haynes C; Dixon C; Thirston L; Ibikunle F; Boswell TA; Alnakhalah A; Contreras J; Bell M; McGuffery T; Bryant S; Nganya C; Kanu S
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
    Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
    Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.
    Kim J; Geyer FC; Martelotto LG; Ng CK; Lim RS; Selenica P; Li A; Pareja F; Fusco N; Edelweiss M; Kumar R; Gularte-Merida R; Forbes AN; Khurana E; Mariani O; Badve S; Vincent-Salomon A; Norton L; Reis-Filho JS; Weigelt B
    J Pathol; 2018 Feb; 244(2):143-150. PubMed ID: 29149504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
    Ramkissoon LA; Horowitz PM; Craig JM; Ramkissoon SH; Rich BE; Schumacher SE; McKenna A; Lawrence MS; Bergthold G; Brastianos PK; Tabak B; Ducar MD; Van Hummelen P; MacConaill LE; Pouissant-Young T; Cho YJ; Taha H; Mahmoud M; Bowers DC; Margraf L; Tabori U; Hawkins C; Packer RJ; Hill DA; Pomeroy SL; Eberhart CG; Dunn IF; Goumnerova L; Getz G; Chan JA; Santagata S; Hahn WC; Stiles CD; Ligon AH; Kieran MW; Beroukhim R; Ligon KL
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8188-93. PubMed ID: 23633565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
    Li M; Li A; Zhou S; Lv H; Yang W
    J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.
    Pei J; Flieder DB; Patchefsky A; Talarchek JN; Cooper HS; Testa JR; Wei S
    Mod Pathol; 2019 Oct; 32(10):1416-1420. PubMed ID: 31028361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.
    Togashi Y; Dobashi A; Sakata S; Sato Y; Baba S; Seto A; Mitani H; Kawabata K; Takeuchi K
    Mod Pathol; 2018 Jun; 31(6):934-946. PubMed ID: 29410490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts.
    Kyrpychova L; Vanecek T; Grossmann P; Martinek P; Steiner P; Hadravsky L; Belousova IE; Shelekhova KV; Svajdler M; Dubinsky P; Michal M; Kazakov DV
    Am J Dermatopathol; 2018 Oct; 40(10):721-726. PubMed ID: 29570128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of novel fusion genes by next-generation sequencing-based targeted RNA sequencing analysis in adenoid cystic carcinoma of head and neck.
    Shibata E; Morita KI; Kayamori K; Tange S; Shibata H; Harazono Y; Michi Y; Ikeda T; Harada H; Imoto I; Yoda T
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Oct; 132(4):426-433. PubMed ID: 34413003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chicken gga-miR-181a targets MYBL1 and shows an inhibitory effect on proliferation of Marek's disease virus-transformed lymphoid cell line.
    Lian L; Li X; Zhao C; Han B; Qu L; Song J; Liu C; Yang N
    Poult Sci; 2015 Nov; 94(11):2616-21. PubMed ID: 26500265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A-MYB (MYBL1) stimulates murine testis-specific Ldhc expression via the cAMP-responsive element (CRE) site.
    Tang H; Goldberg E
    Biol Reprod; 2012 Feb; 86(2):30. PubMed ID: 21998171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BOP1 confers chemoresistance of triple-negative breast cancer by promoting CBP-mediated β-catenin acetylation.
    Li S; Wu H; Huang X; Jian Y; Kong L; Xu H; Ouyang Y; Chen X; Wu G; Yu L; Wang X
    J Pathol; 2021 Jul; 254(3):265-278. PubMed ID: 33797754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of whole-genome sequencing and functional screening identifies a prognostic signature for lung metastasis in triple-negative breast cancer.
    Xie G; Yang H; Ma D; Sun Y; Chen H; Hu X; Jiang YZ; Shao ZM
    Int J Cancer; 2019 Nov; 145(10):2850-2860. PubMed ID: 30977117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
    Brayer KJ; Frerich CA; Kang H; Ness SA
    Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MYB/MYBL1::QKI fusion-positive diffuse glioma.
    Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
    J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible Relationship Between
    Endo Y; Kuwamoto S; Ohira T; Matsushita M; Matsushige T; Fukuhara T; Nakamoto S; Hayashi K; Kugoh H; Hirooka Y
    Yonago Acta Med; 2019 Mar; 62(1):67-76. PubMed ID: 30962747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MYBL1 induces transcriptional activation of ANGPT2 to promote tumor angiogenesis and confer sorafenib resistance in human hepatocellular carcinoma.
    Zhu J; Wu Y; Yu Y; Li Y; Shen J; Zhang R
    Cell Death Dis; 2022 Aug; 13(8):727. PubMed ID: 35987690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A-MYB (MYBL1) transcription factor is a master regulator of male meiosis.
    Bolcun-Filas E; Bannister LA; Barash A; Schimenti KJ; Hartford SA; Eppig JJ; Handel MA; Shen L; Schimenti JC
    Development; 2011 Aug; 138(15):3319-30. PubMed ID: 21750041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYB Proto-oncogene-like 1-TWIST1 Axis Promotes Growth and Metastasis of Hepatocellular Carcinoma Cells.
    Xie B; Liu Y; Zhao Z; Liu Q; Wang X; Xie Y; Liu Y; Liu Y; Yang Y; Long J; Dai Q; Li H
    Mol Ther Oncolytics; 2020 Sep; 18():58-69. PubMed ID: 32637581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.